Intanza®9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age

Acceptance and Opinions of Intanza/IDflu Intradermal Influenza Vaccine in the Czech Republic and Turkey

(2012) Roman Prymula et al.   ADVANCES IN THERAPY

Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany

(2011) Robert Arnou et al.   ADVANCES IN THERAPY

Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina

(2011) Peter Eizenberg et al.   ADVANCES IN THERAPY

Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement

(2011) Filippo Ansaldi et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Fluzone®Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults

(2011) Filippo Ansaldi et al.   Expert Review of Vaccines

Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine

(2011) Paolo Durando et al.   Human vaccines & immunotherapeutics

Transcutaneous and intradermal vaccination

(2011) Behazine Combadiere et al.   Human vaccines & immunotherapeutics

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

(2011) Michael T Osterholm et al.   LANCET INFECTIOUS DISEASES

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults

(2011) Robert W. Frenck et al.   VACCINE

Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave

(2010) Yiting Xue et al.   BMC PUBLIC HEALTH

Intanza® 15 μg Intradermal Seasonal Influenza Vaccine

(2010) Sean T. Duggan et al.   DRUGS & AGING

Intanza®: a new intradermal vaccine for seasonal influenza

(2010) Robert L Atmar et al.   Expert Review of Vaccines

Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials

(2010) Camille Reygrobellet et al.   Human vaccines & immunotherapeutics

Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18–60 years: Randomized, controlled, Phase III trial

(2010) Robert Arnou et al.   Human vaccines & immunotherapeutics

Influenza Vaccines: From Surveillance Through Production to Protection

(2010) Pritish K. Tosh et al.   MAYO CLINIC PROCEEDINGS

Seasonal influenza and vaccination coverage

(2010) Arnold S. Monto   VACCINE

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial

(2009) Jiri Beran et al.   BMC Medicine

Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI©) questionnaire

(2009) Catherine Chevat et al.   Health and Quality of Life Outcomes

Vaccination coverage rates in eleven European countries during two consecutive influenza seasons

(2009) Patricia R. Blank et al.   JOURNAL OF INFECTION

Barriers to Adult Immunization

(2008) David R. Johnson et al.   AMERICAN JOURNAL OF MEDICINE

Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons

(2008) Patricia R Blank et al.   BMC PUBLIC HEALTH

Burden of Influenza‐Like Illness and Effectiveness of Influenza Vaccination among Working Adults Aged 50–64 Years

(2008) Kristin L. Nichol et al.   CLINICAL INFECTIOUS DISEASES

Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice

(2008) Jean-François Nicolas et al.   Expert Review of Vaccines

The Impact of Influenza on Working Days Lost

(2008) Martin Keech et al.   PHARMACOECONOMICS

Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?

(2008) Paul Henri Lambert et al.   VACCINE

Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults

(2008) Isabel Leroux-Roels et al.   VACCINE